Enanta Pharmaceuticals
ENTA
#7285
Rank
C$0.64 B
Marketcap
C$22.27
Share price
5.33%
Change (1 day)
143.39%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -C$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$65.32 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.11 Billion-19.67%
2024 -C$0.14 Billion-23.87%
2023 -C$0.18 Billion4.39%
2022 -C$0.17 Billion-4.4%
2021 -C$0.18 Billion91.12%
2020 -C$91.77 Million-407.13%
2019 C$29.87 M-78.63%
2018 C$0.13 B117.97%
2017 C$64.15 M-574.65%
2016 -C$13.52 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$24.28 Million-137.98%
2012 C$63.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
C$2.28 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.49 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.12 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.71 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.03 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.55 B-21,741.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland